Search results
Sen. Hassan slams GlaxoSmithKline over cost of asthma inhalers
New Hampshire Union Leader· 1 week agoLess than two months after GlaxoSmithKline pledged to cap out-of-pocket costs for its inhalers at...
Abbott India Brushes Off Govt Caps To Post Strong Q4 Print, Shares Gain
Investing.com· 15 hours agoShares of drugmaker Abbott India (NS: ABOT ) were rising on Friday after the company posted strong...
GSK profit drops in first quarter on higher costs
Digital Journal· 1 week agoBritish drugmaker GlaxoSmithKline on Wednesday said its net profit fell 23 percent in the first quarter as the company faced higher exceptional costs...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
WTNH-TV New Haven· 1 week agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 2 weeks agoThe FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, AstraZeneca, ...
5 best blue chip stocks to invest in for sustainable gains in May - excluding Apple Inc. (AAPL) |...
Invezz· 1 week agoYesterday, the biggest company in the world in terms of market cap reported its latest earnings....
GSK Stock Today: Buying An August Covered Call Boosts Your Return By This Much
Investor's Business Daily· 4 days agoA covered call strategy is one way to slightly reduce the risk on a long stock position while also...
The week ahead: Yen, UK and tech earnings along with Fed meeting to fuel market sentiment
The Forex Market· 2 weeks agoGlobal risk sentiment came back with a bang last week, and European, Asian and US markets were a sea...
Amazon, AMD, and Super Micro Sing the Same Sad Song, and 5 Other Things to Know Before Markets Open.
Barrons.com· 1 week agoTesla takes action amid slowing growth at fast-charging stations, Walmart unveils premium...
FTC Challenges 'Bogus' Patents on Ozempic and Other Drugs
MedPage Today· 1 week agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...